AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $691,911 | -89.9% | 9,900 | -89.6% | 0.00% | -91.7% |
| Q2 2023 | $6,868,379 | +340.8% | 95,580 | +373.2% | 0.02% | -14.3% |
| Q4 2022 | $1,558,026 | +535.9% | 20,200 | +267.3% | 0.03% | +460.0% |
| Q3 2022 | $245,000 | -28.6% | 5,500 | -33.7% | 0.01% | -44.4% |
| Q1 2022 | $343,000 | -98.1% | 8,295 | -95.1% | 0.01% | -99.2% |
| Q4 2019 | $17,599,000 | +28285.5% | 170,268 | +854.5% | 1.14% | +3837.9% |
| Q3 2018 | $62,000 | – | 17,838 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |